Skip to content
Cardiovascular healthResearch article3 min read

COVID-19 mRNA vaccine: bigger waist, smoking and hypertension linked to lower antibody levels

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. · Diabetes/metabolism research and reviews · 2021 · Original paper ↗

Key takeaway

In 86 healthcare workers given two doses of the Pfizer/BioNTech vaccine, larger waist circumference (R = -0.324, p = 0.004), smoking, hypertension and longer time since the second dose were associated with lower antibody titres. The sample was small and antibody level is only a surrogate for protection.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Antibody response to COVID-19 vaccines varies between people. The authors looked for health and lifestyle factors associated with how strong the antibody response was after mRNA vaccination.

Who and how

Observational study of 86 healthcare workers enrolled in January-February 2021, each given two Pfizer/BioNTech mRNA vaccine doses 3 weeks apart. Blood was drawn before the first dose and 1-4 weeks after the second. Clinical history, demographics and vaccine side effects were recorded, anthropometrics were measured, and body composition was assessed by dual-energy X-ray absorptiometry. Multivariate analysis adjusted for BMI, age and gender.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    A larger waist circumference was associated with lower antibody titres (R = -0.324, p = 0.004).
  2. 2
    Smokers had lower titres than non-smokers (1099 [1350] vs 1921 [1375], p = 0.007), as did people with hypertension versus normal blood pressure (650 ± 1192 vs 1911 [1364], p = 0.001) and with dyslipidaemia versus normal lipids (534 [972] vs 1872 [1406], p = 0.005).
  3. 3
    In multivariate analysis, higher waist circumference, smoking, hypertension and longer time since the second dose were each associated with lower titres, independent of BMI, age and gender.

Limits & uncertainty

  1. 1
    Only 86 healthcare workers took part, and the groups (for example smokers or hypertensive people) were likely small.
  2. 2
    Antibody titres were the only outcome; the authors state it is not possible to say whether lower antibodies mean a higher likelihood of COVID-19.
  3. 3
    Samples were taken 1-4 weeks after the second dose, so timing differed between people and longer-term responses are not captured.
  4. 4
    Association only: the abstract does not show that these factors cause the lower response. This reading is based on the abstract only.

What to take from it

Waist size, smoking and blood pressure were linked to a weaker antibody response in this small group, which is one more reason these health factors matter. It does not show anyone is unprotected; decisions about boosters or schedules follow public health guidance and clinicians.

Reading your own data

Waist circumference measured the same way at the same time of day, and home blood pressure readings from a validated cuff, are the closest personal measures. Antibody levels themselves are lab tests and cannot be tracked at home.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Aims

To explore variables associated with the serological response following COVID-19 mRNA vaccine.

Methods

Eighty-six healthcare workers adhering to the vaccination campaign against COVID-19 were enrolled in January-February 2021. All subjects underwent two COVID-19 mRNA vaccine inoculations (Pfizer/BioNTech) separated by 3 weeks. Blood samples were collected before the 1st and 1-4 weeks after the second inoculation. Clinical history, demographics, and vaccine side effects were recorded. Baseline anthropometric parameters were measured, and body composition was performed through dual-energy-X-ray absorptiometry.

Results

Higher waist circumference was associated with lower antibody (Ab) titres (R = -0.324, p = 0.004); smokers had lower levels compared to non-smokers [1099 (1350) vs. 1921 (1375), p = 0.007], as well as hypertensive versus normotensive [650 ± 1192 vs. 1911 (1364), p = 0.001] and dyslipideamic compared to those with normal serum lipids [534 (972) vs 1872 (1406), p = 0.005]. Multivariate analysis showed that higher waist circumference, smoking, hypertension, and longer time elapsed since second vaccine inoculation were associated with lower Ab titres, independent of BMI, age. and gender.

Conclusions

Central obesity, hypertension, and smoking are associated with lower Ab titres following COVID-19 vaccination. Although it is currently impossible to determine whether lower SARS-CoV-2 Abs lead to higher likelihood of developing COVID-19, it is well-established that neutralizing antibodies correlate with protection against several viruses including SARS-CoV-2. Our findings, therefore, call for a vigilant approach, as subjects with central obesity, hypertension, and smoking could benefit from earlier vaccine boosters or different vaccine schedules.

Sources & attribution

Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine.

Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, Caputi A, Rossetti R, Spoltore ME, Filippi V, Gangitano E, Manfrini S, Mariani S, Lubrano C, Lenzi A, Mastroianni C, Gnessi L.

Diabetes/metabolism research and reviews · 2021-05-11

DOI: 10.1002/dmrr.3465 ↗PubMed · 33955644 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Observational meta-analysis

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

In-depth explainersRead study →
·Trial meta-analysis

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

In-depth explainersRead study →
·Randomised trial

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

In-depth explainersRead study →
·Validation study/review

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

In-depth explainersRead study →
Cardiovascular health →